436 Local Cases, 27 Imported Cases... 80 More Suspected Vaccine Adverse Reaction Reports

[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Kim Ji-hee] On the 10th, the number of new domestic COVID-19 cases dropped back to the 400s after a week due to the weekend effect.


The Central Disease Control Headquarters (CDCH) announced that as of midnight, 463 new domestic COVID-19 cases were confirmed, bringing the total to 127,772. By infection route, 436 cases were locally transmitted, and 27 were imported. On the day, the number of suspected case tests was 15,137, with 15,137 tests conducted at temporary screening clinics in the metropolitan area and 3,758 tests at temporary screening clinics outside the metropolitan area. A total of 50 confirmed cases were identified at the temporary screening clinics, with 41 in the metropolitan area and 9 outside.


By region, 136 cases were reported in Seoul, 135 in Gyeonggi, and 12 in Incheon, totaling 283 cases in the metropolitan area. Outside the metropolitan area, cases were reported in all regions: 24 in Ulsan, 19 each in Gyeongbuk and Busan, 14 each in Chungnam, Gyeongnam, and Jeju, 9 each in Jeonbuk, Gwangju, and Jeonnam, 7 in Sejong, and 4 each in Daejeon, Chungbuk, and Gangwon.


The cumulative number of COVID-19 deaths increased by one from the previous day to 1,875. The number of critically ill patients increased by one to 161. An additional 421 patients were declared recovered and released from isolation, bringing the total to 117,844.


Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight, 3 new first-dose vaccinations were administered, bringing the total number of people who have completed the first dose to 3,674,729. AstraZeneca vaccine recipients number 2,014,054, and Pfizer vaccine recipients number 1,660,675. An additional 4,734 second-dose vaccinations were administered, bringing the total to 506,274.



The number of suspected adverse reactions reported after COVID-19 vaccination surged by 80 cases from the previous day, reaching a cumulative total of 19,705. Among the newly reported adverse reactions, 5 were major adverse reactions. The rest were mild symptoms such as muscle pain and headache.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing